This brief—the latest in our Tough Times, Tough Choices series—examines the Global Fund’s current approach to resource allocation and the implications of those choices in today’s funding environment. ...

The State Department has announced an initial set of bilateral health cooperation agreements, signing eight memorandums of understanding (MOUs) with governments in sub-Saharan Africa. These compacts a...

The number of children who die before age 5 is expected to rise for the first time this century, amid sweeping cuts to global health funding by high-income countries, according to a new report from th...

The Global Fund is heading into its replenishment with a lofty fundraising goal: $18 billion for the next three years (2026–2028). But in today’s world of shrinking aid budgets, that target might alre...

During COVID, I argued strongly that we should cut the Moderna dose in order to expand supply. In a paper co-authored with Witold Więcek, Michael Kremer and others, we showed that a half dose of Moder...

This event brings together leading experts and policymakers to explore feasible solutions to the current global health financing crisis. The discussion will center on how major global health and devel...

A new PEPFAR blueprint is beginning to take shape, offering a surprisingly strong foundation for a constructive path forward. If backed by real resources and well implemented, it could lay the groundw...

Gavi’s board and leadership must stretch scarce resources to fulfill a challenging double mandate: (1) stabilizing immunization outcomes and fiscal solvency in Gavi-eligible countries facing severe he...

In this brief—the first in the Tough Times, Tough Choices series that will target the major global health and development institutions and their funders—we propose a different approach: radically stre...

The Telegraph joined scientists in Cambodia’s vibrant wet markets and vast bat caves to test revolutionary new disease surveillance tools

Kennedy ripped into Gavi, the Vaccine Alliance, in a video address at its pledging summit.

The US pays—by far—the highest prices for on-patent prescription drugs of any country on earth. The White House just issued an executive order purporting to fix this problem. But the proposed solution...

The US pays—by far—the highest prices for on-patent prescription drugs of any country on earth. The White House just issued an executive order purporting to fix this problem. But the proposed solution...

The US pays—by far—the highest prices for on-patent prescription drugs of any country on earth. The White House just issued an executive order purporting to fix this problem. But the proposed solution...

Preventing and detecting bird flu infections among farmworkers is a key defense against a potential pandemic. Immigration raids and threats have undermined these efforts, researchers say.

Multilateral concessional funds like Gavi or the World Bank’s IDA are the largest source of development finance for the world’s poorest countries. But with shrinking donor commitments, the system need...

Pain is the most costly chronic health problem in the U.S. In latest RIFs at NIH, an entire division devoted to pain research was closed down.

PEPFAR had been set to lead the rollout of Gilead Science's lenacapavir, which has been hailed as a "miracle" of HIV prevention.

The United States was a key supplier of contraceptives in many developing countries. The Trump administration has ended that support.

In a list of thousands of terminated USAID awards that was sent to Congress this week is a devastating cut suggesting the Trump administration might be planning to end funding to Gavi, the global init...

Dismantling of USAID could disrupt many clinical trials and wipe away U.S. “soft power” in developing countries, scientists warn

This policy watch provides an overview of the Trump administration's executive order to pause all foreign aid programs, including for global health, and related actions to date.

A viral claim, spread and amplified by Elon Musk, suggests that only 10 percent of USAID money reaches its intended beneficiaries. This is a wildly incorrect and misleading interpretation of a differe...

Lifesaving treatment and prevention programs for tuberculosis, malaria, H.I.V. and other diseases cannot access funds to continue work.

Pepfar, which is estimated to have delivered lifesaving treatment to as many as 25 million people in 54 countries, faces a funding delay of as long as 180 days.

What will the incoming Trump Administration mean for US funding to multilateral development initiatives? We drill down on US funding for a subset of the major multilateral development, health, and cli...

Study published in Science says a single hemagglutinin mutation, similar to one seen in a Canadian case, could make H5N1 better suited to infect people.